Loading...
Inhibition of p90RSK activation sensitizes triple-negative breast cancer cells to cisplatin by inhibiting proliferation, migration and EMT
Cisplatin (Cis-DDP) is one of the most widely used anti-cancer drugs. It is applicable to many types of cancer, including lung, bladder, and breast cancer. However, its use is now limited because of drug resistance. p90 ribosomal S6 kinase (p90RSK) is one of the downstream effectors in the extracell...
Na minha lista:
| Udgivet i: | BMB Rep |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Korean Society for Biochemistry and Molecular Biology
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6941763/ https://ncbi.nlm.nih.gov/pubmed/31818359 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5483/BMBRep.2019.52.12.234 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|